Title : Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer.

Pub. Date : 2012

PMID : 28210128






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crizotinib is the first orally active inhibitor of receptor tyrosine kinases, including ALK and ROS1, in clinical practice. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens